OOIR: Observatory of International Research

Papers

(The H4-Index of RSC Medicinal Chemistry is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Put a ring on it: application of small aliphatic rings in medicinal chemistry	219
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis	102
Macrocyclization strategies for cyclic peptides and peptidomimetics	102
Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors	71
β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates	69
Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies	66
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics	65
Recent developments on MOF-based platforms for antibacterial therapy	62
Target 2035 – update on the quest for a probe for every protein	54
Fragment-based drug discovery: opportunities for organic synthesis	43
Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors	42
Recent advances in the development of covalent inhibitors	42
A review of the latest research on M^pro targeting SARS-COV inhibitors	39
Ruthenium(ii)–arene complexes as anti-metastatic agents, and related techniques	39
Polarity-based fluorescence probes: properties and applications	34
Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase	34
Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies	34
β-Carboline-based molecular hybrids as anticancer agents: a brief sketch	33
The era of high-quality chemical probes	33
Aloe-emodin derived azoles as a new structural type of potential antibacterial agents: design, synthesis, and evaluation of the action on membrane, DNA, and MRSA DNA isomerase	32
Human carboxylesterases and fluorescent probes to image their activity in live cells	28
Nanoscale, automated, high throughput synthesis and screening for the accelerated discovery of protein modifiers	27
Covalent PROTACs: the best of both worlds?	27
Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides	27
Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors	27

Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics	26
Discovery of novel JAK2 and EGFR inhibitors from a series of thiazole-based chalcone derivatives	26
Porphyromonas gingivalis: where do we stand in our battle against this oral pathogen?	26